Related Experiment Video
Updated: Jan 30, 2026

Mouse Genome Engineering Using Designer Nucleases
Published on: April 2, 2014
Generation of knockout mouse models of cyclin-dependent kinase inhibitors by engineered nuclease-mediated genome
Bo Min Park1, Jae-Il Roh1, Jaehoon Lee1
1Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul, Korea.
Abstract:
Cell cycle dysfunction can cause severe diseases, including neurodegenerative disease and cancer. Mutations in cyclin-dependent kinase inhibitors controlling the G1 phase of the cell cycle are prevalent in various cancers. Mice lacking the tumor suppressors p16 (Cdkn2a, cyclin-dependent kinase inhibitor 2a), p19 (an alternative reading frame product of Cdkn2a,), and p27 (Cdkn1b, cyclin-dependent kinase inhibitor 1b) result in malignant progression of epithelial cancers, sarcomas, and melanomas, respectively. Here, we generated knockout mouse models for each of these three cyclin-dependent kinase inhibitors using engineered nucleases. The p16 and p19 knockout mice were generated via transcription activator-like effector nucleases (TALENs), and p27 knockout mice via clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9 (CRISPR/Cas9). These gene editing technologies were targeted to the first exon of each gene, to induce frameshifts producing premature termination codons. Unlike preexisting embryonic stem cell-based knockout mice, our mouse models are free from selectable markers or other external gene insertions, permitting more precise study of cell cycle-related diseases without confounding influences of foreign DNA.
Insights
Researchers created new mouse models lacking key cell cycle regulators p16, p19, and p27. These precise models aid in studying cell cycle dysfunction and diseases like cancer without foreign DNA interference.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Cell cycle dysfunction is linked to severe diseases, including cancer and neurodegenerative disorders.
- Mutations in cyclin-dependent kinase inhibitors (CKIs) are common in cancers, affecting cell cycle control.
- Loss of tumor suppressors p16, p19, and p27 is associated with specific cancer types.
Purpose of the Study:
- To generate precise knockout mouse models for three critical cell cycle inhibitors: p16, p19, and p27.
- To utilize advanced gene editing techniques for creating these models.
- To enable more accurate research into cell cycle-related diseases by eliminating confounding factors.
Main Methods:
- Generated knockout mouse models for p16 (Cdkn2a) and p19 (Cdkn2a alternative reading frame) using Transcription Activator-Like Effector Nucleases (TALENs).
- Generated knockout mouse models for p27 (Cdkn1b) using Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-Associated Nuclease 9 (CRISPR/Cas9).
- Targeted gene editing to the first exon of each gene to induce frameshifts and premature termination codons, creating functional knockouts.
Main Results:
- Successfully generated p16, p19, and p27 knockout mouse models.
- These models are free from selectable markers or foreign DNA insertions, unlike previous methods.
- The generated models allow for precise investigation of cell cycle regulator functions and related pathologies.
Conclusions:
- The developed gene editing strategies provide precise tools for studying cell cycle regulation.
- These novel knockout mouse models offer a significant advantage for research into cancer and other cell cycle-related diseases.
- Eliminating confounding influences of foreign DNA ensures more accurate and reliable experimental outcomes.
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
CRISPR/Cas9 Genome Editing
cAMP-dependent Protein Kinase Pathways
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
What is Genetic Engineering?
RNA Editing

